(Q36910372)

17 August 2017

Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements (English)

1 reference

17 August 2017

0 references

10

David Dingli

1 reference

17 August 2017

2

Angela Dispenzieri

1 reference

17 August 2017

14

Robert A Kyle

1 reference

17 August 2017

3

Martha Q Lacy

1 reference

17 August 2017

13

Stephen J Russell

1 reference

17 August 2017

15

S Vincent Rajkumar

1 reference

17 August 2017

16

Morie A Gertz

1 reference

17 August 2017

4

Suzanne R Hayman

1 reference

17 August 2017

12

John A Lust

1 reference

17 August 2017

5

Francis K Buadi

1 reference

17 August 2017

1

Shaji Kumar

1 reference

17 August 2017

11

Philip R Greipp

1 reference

17 August 2017

7

Kristina Laumann

1 reference

17 August 2017

6

Colin Colby

1 reference

17 August 2017

8

Steve R Zeldenrust

1 reference

17 August 2017

Nelson Leung

9

1 reference

PMCID

3675680

17 August 2017

language of work or name

English

0 references

publication date

13 February 2012

1 reference

17 August 2017

7

1 reference

Journal of Clinical Oncology

inferred from page(s)

published in

1 reference

17 August 2017

30

1 reference

17 August 2017

9

1 reference

17 August 2017

989-995

1 reference

Amyloidosis: pathogenesis and new therapeutic options.

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675680

Changes in serum-free light chain rather than intact monoclonal immunoglobulin levels predicts outcome following therapy in primary amyloidosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675680

Immunoglobulin light chain amyloidosis: 2011 update on diagnosis, risk-stratification, and management

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675680

Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk score

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675680

Immunophenotyping in multiple myeloma and related plasma cell disorders

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675680

Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical features

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675680

Transplantation for amyloidosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675680

The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675680

International staging system for multiple myeloma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675680

Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675680

N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675680

Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675680

Association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis who are ineligible for stem cell transplantation.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675680

Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675680

Poor tolerance to high doses of thalidomide in patients with primary systemic amyloidosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675680

Stem cell transplantation for the management of primary systemic amyloidosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675680

An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675680

Primary systemic amyloidosis: clinical and laboratory features in 474 cases.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675680

Bortezomib with or without dexamethasone in primary systemic (light chain) amyloidosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675680

Serum free light-chain responses after high-dose intravenous melphalan and autologous stem cell transplantation for AL (primary) amyloidosis.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675680

Plasma cell labeling index

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675680

Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675680

Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675680

Circulating peripheral blood plasma cells as a prognostic indicator in patients with primary systemic amyloidosis

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3675680

Primary systemic amyloidosis: multivariate analysis for prognostic factors in 168 cases

4 December 2018

1 reference

12 December 2020

The plasma cell labeling index: a valuable tool in primary systemic amyloidosis

1 reference

12 December 2020

Safety and efficacy of risk-adapted cyclophosphamide, thalidomide, and dexamethasone in systemic AL amyloidosis

1 reference

12 December 2020

Effect of hematologic response on outcome of patients undergoing transplantation for primary amyloidosis: importance of achieving a complete response

1 reference

12 December 2020

High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis

1 reference

12 December 2020

Autologous stem cell transplant for immunoglobulin light chain amyloidosis: a status report

1 reference

12 December 2020

Identifiers

DOI

10.1200/JCO.2011.38.5724

1 reference

17 August 2017

1 reference

17 August 2017

1 reference

PMCID

3675680